Michael Giaquinto has joined investment bank Greenhill & Co. as a managing director, with a focus on medical devices. He previously was co-head of the
Greenhill & Co., Inc. (NYSE: GHL), a leading independent investment bank, announced today that Michael A. Giaquinto will join the Firm as a Managing Director. Mr. Giaquinto, who most recently served as Co-Head of the U.S. Health Care Group at Citigroup Global Markets, will focus on the Medical Devices sector at Greenhill.
Mr. Giaquinto, 40, spent 18 years covering health care companies as an investment banker, including 10 years at Citigroup (and its predecessors). He also previously worked in the health care group at UBS.
Robert F. Greenhill, Chairman of Greenhill, said “Adding dedicated health care expertise to our Firm has been an important priority for Greenhill. In Michael, we have found someone with deep experience and well established client relationships. We plan to build a substantial advisory business for health care clients over time.”
Scott L. Bok, Co-Chief Executive Officer of Greenhill, added, “We are actively recruiting Managing Directors who can bring us industry sector experience or new geographic reach. Especially in today's market climate, we believe Wall Street talent will be increasingly attracted to Greenhill's simple, focused and successful business model.”
Greenhill & Co., Inc. is a leading independent investment bank that provides financial advice on significant mergers, acquisitions and restructurings and manages merchant banking funds. It acts for clients located throughout the world from its offices in